Takayasu Arteritis Clinical Trials

Find Takayasu Arteritis Clinical Trials Near You

Clinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries Involvement

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

The purpose of this study is to identify the clinical features, management pattern and long-term outcomes of patients with pulmonary arteries involvement in Takayasu's arteritis (TAK-PAI).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Hospitalized between Jan 1, 2016 and Dec 31, 2026

• Diagnosed with TAK according to the modified Ishikawa criteria and/or 1990 American College of Rheumatology criteria and/or 2022 ACR/EULAR criteria

• Diagnosed with pulmonary artery involvement using computed tomography pulmonary angiography or transcatheter pulmonary angiography

• Patients without aortic or primary branch involvement who nonetheless exhibited both clinical features and computed tomography-confirmed evidence of pulmonary artery involvement (PAI), after exclusion of other diseases causing pulmonary artery stenosis or occlusion

Locations
Other Locations
China
China-Japan Friendship hospital
RECRUITING
Beijing
Contact Information
Primary
Wanmu Xie, Doctor
xiewanmu@126.com
15611734410
Time Frame
Start Date: 2016-01-01
Estimated Completion Date: 2026-12-31
Participants
Target number of participants: 150
Treatments
TAK-PAI group
Sponsors
Leads: China-Japan Friendship Hospital

This content was sourced from clinicaltrials.gov